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Several anaesthetics and anaesthetic adjuvants have been shown to limit the extent of 
myocardial injury due to ischaemia and reperfusion, a protective phenomenon known as 
anaesthetic-induced cardioprotection. Inhalational anaesthetics and opioid receptor agonists are 
among the key players in anaesthetic-induced cardioprotection. However, the mechanisms 
underlying anaesthetic-induced cardioprotection are not fully understood, and as such there are 
currently no concrete guidelines regarding the choice of anaesthetic protocols designed to 
enhance cardioprotection. This mini-review provides insights into the mechanisms through 
which the cardioprotection due to inhalational agents and opioid receptor agonists occurs, and 
discusses the clinical implications thereof. The mechanisms underlying this cardioprotection 
are diverse and remain unresolved, but several cellular signaling cascades involve key targets 
such as receptors, sarcolemmal- and mitochondrial ATP-sensitive K
+
 channels, the 
mitochondrial permeability transition pore, glycogen synthase kinase-3 beta, nitric oxide, and 
anti-apoptotic factors. Such factors represent potential therapeutic targets in promoting 
anaesthetic-induced cardioprotection.  






The potential of anaesthetic agents to provide 
perioperative cardioprotection has caused these drugs 
to assume roles that go beyond hypnosis, analgesia and 
muscle relaxation (De Hert et al., 2004, Murphy et al., 
2006). Among anaesthetics and anaesthetic adjuvants, 
volatile agents and opioid receptor agonists, together, 
provide the greatest cardioprotection (Zaugg et al., 
2014). Volatile agents such as halothane, isoflurane, 
and enflurane were among the first anaesthetic drugs to 
be shown to promote post-ischaemic myocardial 
functional recovery and tolerance to ischaemia (Tarnow  
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et al., 1986, Freedman et al., 1985, Warltier et al., 
1988). Subsequently, it was also recognized that 
anaesthetic adjuvants such as opioid receptor agonists 
like morphine (Schultz et al., 1996), fentanyl (Kato et 
al., 2000), and remifentanil (Zhang et al., 2005) 
exhibited substantial cardioprotective effects. Such 
cardioprotective effects of volatile agents and related 
drugs have become known as anaesthetic-induced 
preconditioning and postconditioning, where 
preconditioning provides protection before myocardial 
injury, whereas postconditioning occurs afterwards.  
Anaesthetic-induced cardioprotection has unique 
characteristics that have stimulated a growing interest 
among anaesthesiologists. First, although 
cardioprotection can also be elicited by other 
pharmacological chemicals, anaesthetics have the 
distinct advantage that the beneficial effects of the 
drugs can be obtained even during routine perioperative 
use. Secondly, the cardioprotective effects occur 
independently of the drugs’ cardio-depressant or 
anaesthetic actions. Finally, anaesthetic-induced 
protection also takes place in other major organs like 
the brain, kidneys, lungs, and liver. Unfortunately,  
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Fig. 1.  
Key factors in inhalational anaesthetic and opioid cardiac pre- and postconditioning. See text for details.↑, depicts 
increase and ↓, depicts decrease. Abbreviations: Akt, protein kinase B; ERK, extracellular signal-regulated kinase; GSK, 
glycogen synthase kinase; JAK, janus kinase; KATP channel, ATP-sensitive K
+ 
channel; mPTP, mitochondrial permeability 
transition pore; NOS, nitric oxide synthase; PI3K, phosphatidylinositol-3 kinase; PKC, Ca
2+
-dependent protein kinase; ROS, 
reactive oxygen species; STAT, signal transducer and activator of transcription. 
 
there remains a limited understanding of the 
mechanisms underlying anaesthetic-induced 
cardioprotection. This mini-review presents an 
overview of the key mechanisms through which 
inhalational anaesthetic- and opioid-induced 
cardioprotection take place and highlights the cellular 
targets involved.  
 
Mechanisms underlying inhalational anaesthetic- and 
opioid-induced cardioprotection 
Anaesthetic-induced cardioprotection involves several 
different cellular signaling molecules. Presented below, 
are the key players and processes that link together the 
apparently disparate signaling components (see Fig. 1). 
 
Cell-surface mediators 
Volatile anaesthetics are lipid soluble and are therefore 
able to cross cell membranes without the need for cell-
surface mediators. However, specific cell-surface 
receptors seem to mediate the cardioprotective effects 
of several volatile anaesthetics and opioids. Adenosine 
A1 receptors mediate the preconditioning effects of 
volatile agents isoflurane (Roscoe et al., 2000), 
sevoflurane (Hu et al., 2005) and desflurane (Hanouz et 
al., 2002), and of the opioid fentanyl (Kato et al., 
2000). The adenosine A1 receptors on both myocytes 
and neutrophils have been implicated in this protection 
(Hu et al., 2005). Preconditioning by desflurane also 
occurs through the binding of sarcolemmal α- and β-
adrenergic receptors (Hanouz et al., 2002). For opioid 
drugs, the involvement of sarcolemmal opioid receptors 
plays a pivotal role in mediating the preconditioning- 
and postconditioning effects of morphine (Frassdorf et 
al., 2005, Schultz et al., 1996, Jang et al., 2008, Chen et 
al., 2008b) and remifentanil (Zhang et al., 2005, Yu et 
al., 2007, Wong et al., 2010), as well as the 
preconditioning effects of fentanyl (Gross et al., 2006). 
Among the opioid receptors, the kappa- and delta 
receptor subtypes mediate most of the cardioprotective 
effects. The binding of drugs to these different types of 
receptors leads to downstream effects by opening ATP 
sensitive K
+
 (KATP) channels (Chen et al., 2008b, 
Hanouz et al., 2002, Kato et al., 2000, Schultz et al., 
1996, Roscoe et al., 2000) and thereby modulating 
other signaling molecules discussed in this review.   
 
Modulation of ATP-sensitive K
+
 (KATP) channels and 
other ion channels 
The activation of KATP channels contributes to cardiac 
protection, and has been proposed to be one of the main 
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common effector mechanisms for volatile agents and 
opioid receptor agonists (Patel et al., 2002). Activation 
of sarcolemmal KATP channels hyperpolarizes cells, 
thereby preventing the excitation and contraction of 
ischaemic myocytes. In the mitochondrion, the K
+
 
inflow through KATP channels slightly depolarizes the 
organelle and decreases the electrical driving force for 
mitochondrial Ca
2+
 overload. The stimulation of Ca
2+
-
dependent protein kinase (PKC)-mediated pathways 
appears to be an important pre-step in the activation of 
KATP channels by agents such as isoflurane (Kawano et 
al., 2008) and fentanyl (Zaugg et al., 2002). The 
preconditioning effects of isoflurane are mediated by 
the opening of both sarcolemmal- (Kersten et al., 1997, 
Tonkovic-Capin et al., 2002, Kawano et al., 2008), and 
mitochondrial (Tonkovic-Capin et al., 2002) KATP 
channels. Downstream, the isoflurane-induced 
activation of mitochondrial KATP channels leads to the 
production of protective amounts of reactive oxygen 
species (ROS) (Tanaka et al., 2003), and to the 
inhibition of the mitochondrial permeability transition 
pore (mPTP) (Krolikowski et al., 2005), described 
below. Sevoflurane and desflurane also induce both 
preconditioning and postconditioning through pathways 
involving KATP channels (Lemoine et al., 2008, Hanouz 
et al., 2002, Obal et al., 2005, Mathur et al., 1999). For 
opioids, sarcolemmal KATP channels mediate the pre-
conditioning effects of morphine (Schultz et al., 1996) 
and fentanyl (Kato et al., 2000), whereas mitochondrial  
KATP channels mediate fentanyl preconditioning (Zaugg 
et al., 2002) and morphine postconditioning (Chen et 
al., 2008b). 
Besides KATP channels, other ion channels can also 
mediate anaesthetic-induced cardioprotection. 





 channels (Frassdorf et al., 2010), 





 overload through 
blocking transient receptor potential canonical (TRPC) 
channels (Kojima et al., 2011). This TRPC channel 
effect on Ca
2+ 
is consistent with the known 
cardioprotective action of halothane that is attributed to 
the reduction in intracellular Ca
2+
 (Lochner et al., 
1994).  
  
Glycogen synthase kinase-3 beta (GSK-3β) inhibition 
and the regulation of associated signaling molecules 
The inhibition of glycogen synthase kinase-3 beta 
(GSK-3β) through its phosphorylation is an important 
intracellular step mediating the effects of several 
upstream pathways such as the phosphatidylinositol-3 
kinase (PI3K)/protein kinase B (Akt)-, the janus kinase 
(JAK)/signal transducer and activator of transcription 
(STAT)-, or the extracellular signal-regulated kinase 
(ERK)-dependent pathways. The inhibition of GSK-3β 
underlies the preconditioning effects of morphine and 
fentanyl (Gross et al., 2007a, Gross et al., 2006) as well 
as the postconditioning effects of morphine (Gross et 
al., 2007b) and sevoflurane (Li et al., 2008). The 
GSK-3β inhibitory effects of opioids are mediated by 
pathways involving JAK2 regulation of Akt and 
STAT3 (Gross et al., 2007a, Gross et al., 2006) as well 
as ERK1-dependent signaling (Gross et al., 2007a). The 
postconditioning effects of sevoflurane are mediated by 
the inhibition of GSK-3β via the PI3K/Akt pathway (Li 
et al., 2008). Although desflurane-induced 
preconditioning also involves Akt and ERK1/2 
(Lemoine et al., 2008), any possible link with GSK-3β 
inhibition has not yet been identified. 
The downstream effects of GSK-3β phosphorylation 
include the inhibition of mPTP opening and the 
activation of KATP channels. The mPTP on the 
mitochondrial inner membrane is normally in a closed 
state and ensures the relative mitochondrial 
impermeability, thereby creating a membrane potential 
and optimum organelle volume suitable for energy 
production. During ischaemia, the mPTP tends to 
remain closed due to the effects of lactic acidosis, but at 
the commencement of reperfusion, the pathological 
amounts of ROS, the mitochondrial Ca
2+
 overload, and 
the correction of acidosis lead to the opening of the 
mPTP. The leakage of osmotically-active molecules 
into the organelle through the pore causes 
mitochondrial swelling and uncoupling of the 
respiratory chain that are associated with further ATP 
depletion and the release of pro-apoptotic proteins like 
cytochrome c. Isoflurane preconditioning and 
postconditioning effects are mediated by the inhibition 
of the mPTP through the inhibition of GSK-3β (Pagel 
et al., 2006, Feng et al., 2005), and the activation of 
PKCε (Pravdic et al., 2009). The inhibition of mPTP 
opening is also involved in sevoflurane 
postconditioning (He et al., 2008, Yao et al., 2010), but 
whether GSK-3β plays a role remains unclear. The 
other downstream effect of GSK-3β inhibition is the 
opening of both sarcolemmal- and mitochondrial KATP 
channels such as that which occurs in morphine-
induced postconditioning (Gross et al., 2007b).  
 
Nitric oxide production  
Nitric oxide (NO) is a trigger and mediator of 
anaesthetic-induced cardioprotection. It is a 
downstream factor of signaling pathways such as those 
involving PI3K/Akt and mediates the protective effects 
of cGMP/protein kinase G. In isoflurane 
preconditioning, an initial small release of NO triggers 
nuclear factor-κB to induce the upregulation of the 
inducible NO synthase (iNOS), which enhances further 
production of NO (Chen et al., 2008a). Consistent with 
an essential role for NO in cardioprotection, isoflurane 
preconditioning is absent in a mouse knockout model 
deficient of caveolin-3 (Tsutsumi et al., 2010), a 
Mechanisms underlying anaesthetic-induced cardioprotection 
4    J. Afr. Ass. Physiol. Sci. 3 (1): July, 2015            Gwanyanya and Kelly-Laubscher  
 
scaffolding protein that is known to interact with both 
endothelial NO synthase (eNOS) and the eNOS 
regulator Hsp90 (Garcia-Cardena et al., 1996). The 
isoflurane-induced eNOS activity is also dependent on 
the co-localization of eNOS with Hsp90 and on the 
presence of the other eNOS regulator 
tetrahydrobioprotein (Amour et al., 2010). Isoflurane 
postconditioning also occurs through PI3K/Akt-
dependent NO production, and is linked to eNOS-
dependent production of NO via the activation of 
ERK1/2 and ribosomal protein p70s6K signaling 
pathways (Krolikowski et al., 2006). Among opioids, 
the morphine postconditioning effects, involving the 
inhibition of mPTP, are mediated by NO via 
cGMP/protein kinase G pathway (Jang et al., 2008). 
 
Prevention of apoptosis 
Preconditioning with isoflurane, sevoflurane and 
remifentanil, as well as postconditioning with 
sevoflurane have all been associated with decreases in 
apoptotic factors. Isoflurane preconditioning promotes 
cell survival by decreasing the expression of the pro-
apoptotic factor Bax and by increasing anti-apoptotic 
factors Bcl-2 and Bad via the PI3K/Akt pathway 
(Raphael et al., 2005, Raphael et al., 2006). 
Sevoflurane decreases cell death due to apoptosis 
through ROS-dependent activation of nuclear 
transcription factor-κB and through increased 
expression of Bcl-2 (Lu et al., 2009). The remifentanil 
preconditioning via ERK1/2-dependent pathways is 
associated with increased expression of Bcl-2, and with 
decreased expression of pro-apoptotic factors Bax and 
cytochrome c (Kim et al., 2010). Postconditioning with 
sevoflurane decreases infarct size via PI3K- and 
ERK1/2-dependent inhibition of caspase 3 and 9 
activity (Inamura et al., 2010).  
 
Changes in the levels of reactive oxygen species 
(ROS) 
ROS generated from the mitochondria during oxidative 
stress can be either toxic or protective, probably 
depending on factors such as the amount produced, the 
type of feedback to the mitochondria, or the nature of 
interactions between ROS and nitric oxide. 
Preconditioning with both isoflurane and sevoflurane 
can increase ROS production, and this increase has 
been implicated in cardioprotection (Tanaka et al., 
2002, Tanaka et al., 2003, Mullenheim et al., 2002, 
Shiomi et al., 2014). Furthermore, isoflurane decreases 
oxidative stress-induced lipid peroxidation and 
maintains the integrity of the mitochondrial respiratory 
chain (Lotz et al., 2015). In contrast to these effects, 
isoflurane-induced production of ROS promotes Ca
2+
 
overload during ischaemia (Dworschak et al., 2004) 
and in some studies isoflurane-induced preconditioning 
decreased ROS production (Tanaka et al., 2002, Sedlic 
et al., 2010). Thus, for isoflurane, the exact role of ROS 
remains unclear.  
Other factors 
Apart from the above-mentioned key players and 
processes, other factors such as translocation of 
proteins within cell membranes, activation of enzymes 
and regulatory proteins and protection of the 
endothelial glycocalyx also contribute to anaesthetic-
induced cardioprotection. Isoflurane preconditioning 
requires the translocation of the proteins caveolin-3 and 
glucose transporter (GLUT)-4 to the membrane 
caveolae (Tsutsumi et al., 2010). It also induces PKCε-
mediated phosphorylation of mitochondrial aldehyde 
dehydrogenase (ALDH)-2, which metabolises toxic 
aldehydes (Lang et al., 2013), as well as the adenosine 
monophosphate protein kinase (AMPK)- and PKCε-
mediated increase of the cytokine macrophage 
migration inhibitory factor (MIF) (Goetzenich et al., 
2014). The enzyme cyclooxygenase 2 also plays a role 
in isoflurane-induced preconditioning (Alcindor et al., 
2004), but its involvement in mediating the actions of 
other agents is still not known. The preconditioning and 
postconditioning effects of sevoflurane are proposed to 
protect the endothelial glycocalyx from degradation by 
minimizing endothelial cell adhesion (Chappell et al., 
2011) and by decreasing the activity of lysosomal 
proteases (Annecke et al., 2010).  
 
Clinical implications  
The evaluation of the impact of the use of specific 
anaesthetic protective protocols in clinical practice has 
inherent limitations, given the nature of 
anaesthesiology as a polypharmacy practice and the 
medical- or surgery-related confounding factors. As a 
result, there are currently no clear recommendations 
regarding the choices of anaesthetic protocols. In 
patients undergoing cardiac surgery, isoflurane and 
morphine have been shown to be protective in 
preconditioning protocols (Belhomme et al., 1999, 
Murphy et al., 2006). In another group of similar 
patients, sevoflurane and desflurane were associated 
with shorter intensive care unit (ICU) and hospital stays 
compared to propofol and midazolam, but there were 
no differences in the incidences of post-operative 
complications (De Hert et al., 2004). In contrast, in 
other patients undergoing coronary artery surgery, the 
choice of anaesthetic regimen did not change the 
incidence of complications or the duration of stay in the 
ICU (Tuman et al., 1989). In addition, volatile agents 
themselves can diminish the collateral cardioprotection 
that occurs through the preconditioning in other organs 
(Zhou et al., 2013). Similarly, although the intravenous 
anaesthetic agent propofol itself is cardioprotective (He 
et al., 2008, Mathur et al., 1999), it also inhibits 
desflurane-induced preconditioning in rabbit hearts 
Mechanisms underlying anaesthetic-induced cardioprotection 
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(Smul et al., 2011). Therefore, besides the lack of 
clarity concerning the precise nature of anaesthetic-
induced cardioprotection in clinical practice, there is 
also a potential for interference from co-administered 
anaesthetics (Zaugg et al., 2014).  
 
CONCLUSIONS 
The potential benefits of anaesthetic-induced 
cardioprotection present an opportunity to design 
anaesthetic protocols that maximise perioperative 
myocardial survival. The mechanisms underlying 
inhalational anaesthetic- and opioid receptor agonist-
induced cardioprotection are diverse and a lot still 
remains unknown, but most of the cellular signaling 
cascades involved converge onto key targets such as 
KATP channels, mPTP, GSK-3β, NO and ROS. There 
are also other molecules involved whose exact roles 
and connections to mainstream pathways still require 
further clarifications in future studies. A better 
understanding of the mechanisms underlying 
anaesthetic-induced cardioprotection is needed to 
facilitate the formulation of concrete clinical guidelines 
that take advantage of the drugs’ protective 
characteristics.  
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